RxDoctor Payments Data

Sanjay Sikka, MD

Gastroenterology · Oklahoma City, OKNPI 1528295698

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 72.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $20,330 and has fallen 90.2% since, to $1,996 in 2025. Among gastroenterology clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,825in general payments, 2019–2025

Across 211 payments — averaging $146.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$22K
  • Olympus Corporation Of The Americas$5K
  • Cook Medical LLC$1K
  • Olympus America Inc.$676
  • AbbVie$351
  • Lumendi LLC$223
  • plus $829 from 13 others

What the payments were for

  • Speaking & faculty fees$10,20033%
  • Travel & lodging$12,71741%
  • Food & beverage$7,85525%
  • Gifts$530%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,825 in reported general payments places this provider in the 90th percentile of 133 gastroenterology providers in Oklahoma.

See all gastroenterology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$124,802
Medicare patients
257
Services billed
669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ursodiol13$1,381
Omeprazole16$377
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl23$371
Lidocaine Hcl ViscousLidocaine Hcl13$97
Ciprofloxacin Hcl25$86

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →